Stapje vooruit behandeling Graves-oogziekte

Graag met vermelding van de bron
Eekhoorn
Berichten: 162
Lid geworden op: 13 okt 2013, 12:09

Stapje vooruit behandeling Graves-oogziekte

Bericht door Eekhoorn »

Teprotumumab for Thyroid-Associated Ophthalmopathy

Thyroid-associated ophthalmopathy, a condition commonly associated with Graves’ disease, remains inadequately treated. Current medical therapies, which primarily consist of glucocorticoids, have limited efficacy and present safety concerns. Inhibition of the insulin-like growth factor I receptor (IGF-IR) is a new therapeutic strategy to attenuate the underlying autoimmune pathogenesis of ophthalmopathy.

[...]

Conclusions
In patients with active ophthalmopathy, teprotumumab was more effective than placebo in reducing proptosis and the Clinical Activity Score

http://www.nejm.org/doi/full/10.1056/NEJMoa1614949
Plaats reactie